via Monash University
A multi-disciplinary project driven by EMBL Australia researchers at Monash University and Harvard University has found a way to make antibiotics more effective against antibiotic-resistant bacteria – also known as ‘superbugs.
Antimicrobial resistance to superbugs has been evolving and is one of the top 10 global public health threats facing humanity, according to the World Health Organization.
This new research will provide a pathway to increasing the effectiveness of antibiotics, without clinicians having to resort to risky strategies of giving patients higher doses or relying on the discovery of new types of antibiotics.
During a bacterial infection, the body uses molecules called chemoattractants to recruit neutrophils to the site of the infection. Neutrophils are immune cells with the ability to encapsulate and kill dangerous bacteria, critical to the immune response. Researchers attached a chemoattractant to an antibiotic, enabling them to enhance the recruitment of immune cells and improve their killing ability.
The findings have now been published in Nature Communications.
“When looking at how our immune system can fight bacteria there are two important aspects we look at. The first is our ability to entrap bacterial cells and kill them. The second is the signals – the chemoattractants – calling for more neutrophils, white blood cells which lead the immune system’s response to resolve infection,” said Dr Jennifer Payne, the lead researcher from EMBL Australia and the Monash Biomedicine Discovery Institute.
The researchers linked a chemoattractant known as formyl peptide to vancomycin, a commonly used antibiotic that binds to the surface of the bacteria, and performed their studies on golden staph infections, one of the more problematic antibiotic-resistant bacteria.
“We’ve been working on using dual-function antibiotic-chemoattractant ‘hybrids’, which improve the recruitment of neutrophils and increase the engulfing and killing of the bacteria,” said Dr Payne.
“By stimulating our powerful immune system in this way with the immunotherapeutic antibiotic, we’ve shown in mouse models that the treatment is 2-fold more effective than just using the antibiotic alone at one-fifth lower dose,” said Associate Professor Max Cryle, an EMBL Australia Group Leader at the Monash Biomedicine Discovery Institute.
“This very promising new avenue of research is bringing a lot of potential benefits to the ever-increasing threat of drug-resistant superbugs,” said Associate Professor Cryle.
Instrumental to the project was funding from VESKI and Melbourne sister city foundation that took Dr Payne across the world to Boston to learn and carry out microfluidic research learning and collaborating with Associate Professor Daniel Irima, and Dr Felix Ellett, Harvard experts in this field.
“Microfluidics was ground-breaking for this research, as it allowed us to generate an infection-on-a-chip to monitor the recruitment of human immune cells, and observe in real-time how our immunotherapeutic enhances their ability to kill MRSA. Just like what would happen in our body” said Dr Payne,
Partners are being sought to continue this research into clinical trials with the potential of developing a preventative antibiotic strategy in the intensive care environment to protect our most vulnerable.
The work has resulted in a patent covering the immunotherapeutic, with the IP owned by Monash University.
Original Article: Researchers discover a way to increase the effectiveness of antibiotics
The Latest on: Antibiotic effectiveness
- Florida shuts down all monoclonal antibody treatment sites after FDA decision to limit use of certain treatments not proven effective against Omicronon January 25, 2022 at 12:25 am
At a press conference, Gov. Ron DeSantis (R-FL) said that some nurses don't want to get the Covid-19 vaccines because they are trying to get pregnant. However, current studies show there is no ...
- No USFDA approval for Merck cough drug Gefapixanton January 24, 2022 at 11:17 pm
Merck & Co said on Monday the U.S. Food and Drug Administration declined to approve its experimental drug for the treatment of chronic cough and sought additional information on ...
- 30 traffickers among 157 nabbed in Malacca anti-drug raidson January 24, 2022 at 10:44 pm
POLICE have arrested 157 people, including 30 drug dealers, and seized various types of drugs worth RM60,600 in a three-day operation in Malacca beginning January 21. Malacca Narcotics Criminal ...
- Evotec Signs IPSC-based Drug Discovery Partnership With Boehringer Ingelheim In Ophthalmologyon January 24, 2022 at 10:10 pm
Evotec AG (EVTCY.PK), a German drug discovery and development company, Tuesday said it has entered into a target and drug discovery partnership with Boehringer Ingelheim in ophthalmology. The ...
- Insilico Medicine Applauded by Frost & Sullivan for Enabling Rapid and Cost-Effective Drug Discovery and Development with Its Pharma.AI Platformon January 24, 2022 at 9:23 pm
Based on its recent analysis of the global artificial intelligence (AI)-enabled drug discovery industry, Frost & Sullivan recognizes Insilico Medicine with the 2022 Entrepreneurial Company of the Year ...
- Making sense of controversy over the new Alzheimer’s drugon January 24, 2022 at 2:50 pm
The medication has shown some promise at addressing what may be an underlying cause of the disease, but its ability to slow or reverse cognitive decline remains unproven.
- Steroids side effects: The 'widespread effects' the drug can have on the body - Dr Chrison January 24, 2022 at 1:54 am
STEROIDS, also called corticosteroids, are anti-inflammatory medicines used to treat a range of conditions. However, taking them can give rise to sinister side effects. Speaking on ITV's This Morning, ...
- Lakeland Regional joins national study to see if ivermectin is effective against COVID-19on January 23, 2022 at 3:01 am
Local health leaders pushed back against his messaging, saying the drug has adverse side effects, and that there isn’t enough evidence to prove it treats the virus. Now, the county’s largest hospital ...
- Antibiotic-resistant infections are a ‘major global health threat’ that’s killing millions, scientists sayon January 20, 2022 at 3:16 am
A huge new global study found that drug-resistant bacterial infections played a part in almost 5 million deaths in 2019.
- Investigational cancer drug mimics the metabolic and therapeutic effects of fasting, mice study showson January 19, 2022 at 6:23 pm
An investigational cancer drug that starves tumors of their energy supply also shows evidence of improving whole body metabolism, according to a new study in mice from Washington University School of ...
via Bing News
The Latest on: Antibiotic effectiveness
via Google News